Harvey completed his PhD in Cancer Proteomics at the University of Southampton characterising B-cell tumours focusing on chronic lymphocytic leukaemia in addition to applying plasma proteomics to identify cancer biomarkers. He continued his PhD research working as a post-doc in Southampton and later joined the Cancer Proteomics Group at UCL working as a ¶¶Òõ¶ÌÊÓƵ Associate in biomarker discovery.
Harvey is a currently a Postdoctoral ¶¶Òõ¶ÌÊÓƵ Scientist working in Rahul Samant’s Group to understand mechanisms of misfolded protein clearance using proteomics. His work primarily involves the development and application of methods to characterise ubiquitylated proteins by mass spectrometry.